nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1A1—head and neck cancer	0.34	1	CbGaD
Lansoprazole—MAPT—Docetaxel—head and neck cancer	0.299	0.596	CbGbCtD
Lansoprazole—CYP1B1—Docetaxel—head and neck cancer	0.0474	0.0945	CbGbCtD
Lansoprazole—ABCG2—Fluorouracil—head and neck cancer	0.0295	0.0588	CbGbCtD
Lansoprazole—CYP2D6—Hydroxyurea—head and neck cancer	0.0262	0.0523	CbGbCtD
Lansoprazole—ABCG2—Docetaxel—head and neck cancer	0.0225	0.0449	CbGbCtD
Lansoprazole—CYP2C8—Fluorouracil—head and neck cancer	0.0157	0.0313	CbGbCtD
Lansoprazole—CYP1A2—Fluorouracil—head and neck cancer	0.0122	0.0243	CbGbCtD
Lansoprazole—CYP2C9—Fluorouracil—head and neck cancer	0.011	0.0219	CbGbCtD
Lansoprazole—ABCB1—Vinblastine—head and neck cancer	0.00985	0.0197	CbGbCtD
Lansoprazole—CYP2D6—Vinblastine—head and neck cancer	0.00928	0.0185	CbGbCtD
Lansoprazole—ABCB1—Docetaxel—head and neck cancer	0.00812	0.0162	CbGbCtD
Lansoprazole—CYP3A4—Vinblastine—head and neck cancer	0.0059	0.0118	CbGbCtD
Lansoprazole—CYP3A4—Docetaxel—head and neck cancer	0.00487	0.00971	CbGbCtD
Lansoprazole—Thiabendazole—CYP1A1—head and neck cancer	0.00265	0.636	CrCbGaD
Lansoprazole—ATP4A—larynx—head and neck cancer	0.00182	0.319	CbGeAlD
Lansoprazole—Rabeprazole—CYP1A1—head and neck cancer	0.000834	0.2	CrCbGaD
Lansoprazole—Omeprazole—CYP1A1—head and neck cancer	0.00068	0.163	CrCbGaD
Lansoprazole—ATP4A—neck—head and neck cancer	0.000481	0.0847	CbGeAlD
Lansoprazole—ATP4A—connective tissue—head and neck cancer	0.000345	0.0607	CbGeAlD
Lansoprazole—ATP4A—epithelium—head and neck cancer	0.000327	0.0576	CbGeAlD
Lansoprazole—Amnesia—Fluorouracil—head and neck cancer	0.00031	0.00393	CcSEcCtD
Lansoprazole—MAPT—thyroid gland—head and neck cancer	0.000309	0.0543	CbGeAlD
Lansoprazole—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000305	0.00387	CcSEcCtD
Lansoprazole—Hypoaesthesia—Vinblastine—head and neck cancer	0.000305	0.00387	CcSEcCtD
Lansoprazole—Pharyngitis—Vinblastine—head and neck cancer	0.000304	0.00386	CcSEcCtD
Lansoprazole—Stomatitis—Hydroxyurea—head and neck cancer	0.000303	0.00385	CcSEcCtD
Lansoprazole—Inflammation—Docetaxel—head and neck cancer	0.000298	0.00378	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000294	0.00374	CcSEcCtD
Lansoprazole—Osteoarthritis—Fluorouracil—head and neck cancer	0.000291	0.00369	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000291	0.00369	CcSEcCtD
Lansoprazole—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000289	0.00367	CcSEcCtD
Lansoprazole—Injection site reaction—Docetaxel—head and neck cancer	0.000287	0.00365	CcSEcCtD
Lansoprazole—CYP1B1—hair follicle—head and neck cancer	0.000286	0.0502	CbGeAlD
Lansoprazole—Hallucination—Hydroxyurea—head and neck cancer	0.000278	0.00353	CcSEcCtD
Lansoprazole—Colitis—Docetaxel—head and neck cancer	0.000278	0.00352	CcSEcCtD
Lansoprazole—Candida infection—Docetaxel—head and neck cancer	0.000276	0.0035	CcSEcCtD
Lansoprazole—Neuropathy—Docetaxel—head and neck cancer	0.000271	0.00344	CcSEcCtD
Lansoprazole—Alopecia—Vinblastine—head and neck cancer	0.000271	0.00344	CcSEcCtD
Lansoprazole—Dry skin—Fluorouracil—head and neck cancer	0.000267	0.00338	CcSEcCtD
Lansoprazole—Oesophagitis—Docetaxel—head and neck cancer	0.000264	0.00335	CcSEcCtD
Lansoprazole—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00026	0.0033	CcSEcCtD
Lansoprazole—Muscular weakness—Fluorouracil—head and neck cancer	0.000256	0.00325	CcSEcCtD
Lansoprazole—Angiopathy—Hydroxyurea—head and neck cancer	0.000254	0.00322	CcSEcCtD
Lansoprazole—Dysphagia—Fluorouracil—head and neck cancer	0.000251	0.00319	CcSEcCtD
Lansoprazole—Chills—Hydroxyurea—head and neck cancer	0.000251	0.00318	CcSEcCtD
Lansoprazole—Eosinophilia—Fluorouracil—head and neck cancer	0.000249	0.00316	CcSEcCtD
Lansoprazole—Ill-defined disorder—Vinblastine—head and neck cancer	0.000248	0.00314	CcSEcCtD
Lansoprazole—Alopecia—Hydroxyurea—head and neck cancer	0.000247	0.00313	CcSEcCtD
Lansoprazole—Anaemia—Vinblastine—head and neck cancer	0.000247	0.00313	CcSEcCtD
Lansoprazole—Angina pectoris—Fluorouracil—head and neck cancer	0.000245	0.00311	CcSEcCtD
Lansoprazole—Erythema—Hydroxyurea—head and neck cancer	0.000243	0.00309	CcSEcCtD
Lansoprazole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000241	0.00306	CcSEcCtD
Lansoprazole—Malaise—Vinblastine—head and neck cancer	0.000241	0.00305	CcSEcCtD
Lansoprazole—Vertigo—Vinblastine—head and neck cancer	0.00024	0.00304	CcSEcCtD
Lansoprazole—Leukopenia—Vinblastine—head and neck cancer	0.000239	0.00303	CcSEcCtD
Lansoprazole—Pancytopenia—Fluorouracil—head and neck cancer	0.000239	0.00303	CcSEcCtD
Lansoprazole—Deafness—Docetaxel—head and neck cancer	0.000235	0.00298	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000234	0.00296	CcSEcCtD
Lansoprazole—Convulsion—Vinblastine—head and neck cancer	0.000231	0.00293	CcSEcCtD
Lansoprazole—Hypertension—Vinblastine—head and neck cancer	0.00023	0.00292	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000229	0.00291	CcSEcCtD
Lansoprazole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000226	0.00286	CcSEcCtD
Lansoprazole—Pneumonia—Fluorouracil—head and neck cancer	0.000225	0.00286	CcSEcCtD
Lansoprazole—Anaemia—Hydroxyurea—head and neck cancer	0.000225	0.00285	CcSEcCtD
Lansoprazole—Discomfort—Vinblastine—head and neck cancer	0.000224	0.00285	CcSEcCtD
Lansoprazole—Hot flush—Docetaxel—head and neck cancer	0.000224	0.00285	CcSEcCtD
Lansoprazole—Infestation—Fluorouracil—head and neck cancer	0.000224	0.00284	CcSEcCtD
Lansoprazole—Infestation NOS—Fluorouracil—head and neck cancer	0.000224	0.00284	CcSEcCtD
Lansoprazole—Menopausal symptoms—Docetaxel—head and neck cancer	0.000222	0.00282	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000221	0.0028	CcSEcCtD
Lansoprazole—Renal impairment—Docetaxel—head and neck cancer	0.000221	0.0028	CcSEcCtD
Lansoprazole—Myocardial infarction—Fluorouracil—head and neck cancer	0.00022	0.00279	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00022	0.00279	CcSEcCtD
Lansoprazole—Malaise—Hydroxyurea—head and neck cancer	0.000219	0.00278	CcSEcCtD
Lansoprazole—Stomatitis—Fluorouracil—head and neck cancer	0.000218	0.00277	CcSEcCtD
Lansoprazole—Conjunctivitis—Fluorouracil—head and neck cancer	0.000218	0.00276	CcSEcCtD
Lansoprazole—Urinary tract infection—Fluorouracil—head and neck cancer	0.000218	0.00276	CcSEcCtD
Lansoprazole—Leukopenia—Hydroxyurea—head and neck cancer	0.000218	0.00276	CcSEcCtD
Lansoprazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.000213	0.0027	CcSEcCtD
Lansoprazole—Epistaxis—Fluorouracil—head and neck cancer	0.000211	0.00268	CcSEcCtD
Lansoprazole—Convulsion—Hydroxyurea—head and neck cancer	0.000211	0.00267	CcSEcCtD
Lansoprazole—Hyponatraemia—Docetaxel—head and neck cancer	0.000211	0.00267	CcSEcCtD
Lansoprazole—Sinusitis—Fluorouracil—head and neck cancer	0.00021	0.00267	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00021	0.00266	CcSEcCtD
Lansoprazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000209	0.00265	CcSEcCtD
Lansoprazole—Anorexia—Vinblastine—head and neck cancer	0.000208	0.00263	CcSEcCtD
Lansoprazole—Migraine—Docetaxel—head and neck cancer	0.000207	0.00262	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000206	0.00261	CcSEcCtD
Lansoprazole—Discomfort—Hydroxyurea—head and neck cancer	0.000205	0.0026	CcSEcCtD
Lansoprazole—ATP4A—head—head and neck cancer	0.000203	0.0357	CbGeAlD
Lansoprazole—Rhinitis—Fluorouracil—head and neck cancer	0.000202	0.00256	CcSEcCtD
Lansoprazole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0002	0.00254	CcSEcCtD
Lansoprazole—Pharyngitis—Fluorouracil—head and neck cancer	0.0002	0.00253	CcSEcCtD
Lansoprazole—Oedema—Hydroxyurea—head and neck cancer	0.000199	0.00252	CcSEcCtD
Lansoprazole—Infection—Hydroxyurea—head and neck cancer	0.000197	0.0025	CcSEcCtD
Lansoprazole—Paraesthesia—Vinblastine—head and neck cancer	0.000196	0.00248	CcSEcCtD
Lansoprazole—Dehydration—Docetaxel—head and neck cancer	0.000195	0.00248	CcSEcCtD
Lansoprazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000195	0.00247	CcSEcCtD
Lansoprazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000194	0.00247	CcSEcCtD
Lansoprazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.000194	0.00246	CcSEcCtD
Lansoprazole—Skin disorder—Hydroxyurea—head and neck cancer	0.000193	0.00245	CcSEcCtD
Lansoprazole—Dry skin—Docetaxel—head and neck cancer	0.000192	0.00244	CcSEcCtD
Lansoprazole—MAPT—lymph node—head and neck cancer	0.000192	0.0337	CbGeAlD
Lansoprazole—Breast disorder—Docetaxel—head and neck cancer	0.00019	0.00241	CcSEcCtD
Lansoprazole—Anorexia—Hydroxyurea—head and neck cancer	0.000189	0.0024	CcSEcCtD
Lansoprazole—Decreased appetite—Vinblastine—head and neck cancer	0.000189	0.0024	CcSEcCtD
Lansoprazole—Cramp muscle—Docetaxel—head and neck cancer	0.000189	0.0024	CcSEcCtD
Lansoprazole—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000189	0.0024	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000189	0.0024	CcSEcCtD
Lansoprazole—Nasopharyngitis—Docetaxel—head and neck cancer	0.000188	0.00238	CcSEcCtD
Lansoprazole—Constipation—Vinblastine—head and neck cancer	0.000186	0.00236	CcSEcCtD
Lansoprazole—Pain—Vinblastine—head and neck cancer	0.000186	0.00236	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000185	0.00235	CcSEcCtD
Lansoprazole—Dysphagia—Docetaxel—head and neck cancer	0.000181	0.0023	CcSEcCtD
Lansoprazole—Arrhythmia—Fluorouracil—head and neck cancer	0.00018	0.00228	CcSEcCtD
Lansoprazole—Feeling abnormal—Vinblastine—head and neck cancer	0.000179	0.00228	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000178	0.00226	CcSEcCtD
Lansoprazole—Alopecia—Fluorouracil—head and neck cancer	0.000178	0.00226	CcSEcCtD
Lansoprazole—Dyspnoea—Hydroxyurea—head and neck cancer	0.000177	0.00225	CcSEcCtD
Lansoprazole—Angina pectoris—Docetaxel—head and neck cancer	0.000177	0.00224	CcSEcCtD
Lansoprazole—Somnolence—Hydroxyurea—head and neck cancer	0.000177	0.00224	CcSEcCtD
Lansoprazole—Erythema—Fluorouracil—head and neck cancer	0.000175	0.00222	CcSEcCtD
Lansoprazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.000175	0.00222	CcSEcCtD
Lansoprazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.000173	0.00219	CcSEcCtD
Lansoprazole—Pancytopenia—Docetaxel—head and neck cancer	0.000172	0.00219	CcSEcCtD
Lansoprazole—Abdominal pain—Vinblastine—head and neck cancer	0.000172	0.00218	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000171	0.00218	CcSEcCtD
Lansoprazole—Fatigue—Hydroxyurea—head and neck cancer	0.000171	0.00217	CcSEcCtD
Lansoprazole—Pain—Hydroxyurea—head and neck cancer	0.00017	0.00215	CcSEcCtD
Lansoprazole—Constipation—Hydroxyurea—head and neck cancer	0.00017	0.00215	CcSEcCtD
Lansoprazole—Neutropenia—Docetaxel—head and neck cancer	0.00017	0.00215	CcSEcCtD
Lansoprazole—Weight increased—Docetaxel—head and neck cancer	0.000165	0.00209	CcSEcCtD
Lansoprazole—Vision blurred—Fluorouracil—head and neck cancer	0.000165	0.00209	CcSEcCtD
Lansoprazole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000164	0.00208	CcSEcCtD
Lansoprazole—Pneumonia—Docetaxel—head and neck cancer	0.000163	0.00206	CcSEcCtD
Lansoprazole—Anaemia—Fluorouracil—head and neck cancer	0.000162	0.00205	CcSEcCtD
Lansoprazole—Infestation NOS—Docetaxel—head and neck cancer	0.000162	0.00205	CcSEcCtD
Lansoprazole—Infestation—Docetaxel—head and neck cancer	0.000162	0.00205	CcSEcCtD
Lansoprazole—Hypersensitivity—Vinblastine—head and neck cancer	0.00016	0.00204	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00016	0.00203	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000159	0.00202	CcSEcCtD
Lansoprazole—Renal failure—Docetaxel—head and neck cancer	0.000159	0.00202	CcSEcCtD
Lansoprazole—Myocardial infarction—Docetaxel—head and neck cancer	0.000159	0.00201	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000159	0.00201	CcSEcCtD
Lansoprazole—CYP1A1—mouth—head and neck cancer	0.000158	0.0279	CbGeAlD
Lansoprazole—Jaundice—Docetaxel—head and neck cancer	0.000158	0.002	CcSEcCtD
Lansoprazole—Stomatitis—Docetaxel—head and neck cancer	0.000158	0.002	CcSEcCtD
Lansoprazole—Conjunctivitis—Docetaxel—head and neck cancer	0.000157	0.00199	CcSEcCtD
Lansoprazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000157	0.00199	CcSEcCtD
Lansoprazole—Leukopenia—Fluorouracil—head and neck cancer	0.000157	0.00199	CcSEcCtD
Lansoprazole—Asthenia—Vinblastine—head and neck cancer	0.000156	0.00198	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000153	0.00194	CcSEcCtD
Lansoprazole—Epistaxis—Docetaxel—head and neck cancer	0.000153	0.00194	CcSEcCtD
Lansoprazole—Convulsion—Fluorouracil—head and neck cancer	0.000152	0.00193	CcSEcCtD
Lansoprazole—Agranulocytosis—Docetaxel—head and neck cancer	0.000151	0.00192	CcSEcCtD
Lansoprazole—Myalgia—Fluorouracil—head and neck cancer	0.000149	0.00189	CcSEcCtD
Lansoprazole—Chest pain—Fluorouracil—head and neck cancer	0.000149	0.00189	CcSEcCtD
Lansoprazole—Diarrhoea—Vinblastine—head and neck cancer	0.000149	0.00189	CcSEcCtD
Lansoprazole—Discomfort—Fluorouracil—head and neck cancer	0.000147	0.00187	CcSEcCtD
Lansoprazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000146	0.00186	CcSEcCtD
Lansoprazole—Rhinitis—Docetaxel—head and neck cancer	0.000146	0.00185	CcSEcCtD
Lansoprazole—Hepatitis—Docetaxel—head and neck cancer	0.000145	0.00184	CcSEcCtD
Lansoprazole—Hypoaesthesia—Docetaxel—head and neck cancer	0.000144	0.00183	CcSEcCtD
Lansoprazole—Confusional state—Fluorouracil—head and neck cancer	0.000144	0.00183	CcSEcCtD
Lansoprazole—Pharyngitis—Docetaxel—head and neck cancer	0.000144	0.00183	CcSEcCtD
Lansoprazole—Dizziness—Vinblastine—head and neck cancer	0.000144	0.00183	CcSEcCtD
Lansoprazole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000143	0.00182	CcSEcCtD
Lansoprazole—Oedema peripheral—Docetaxel—head and neck cancer	0.000143	0.00181	CcSEcCtD
Lansoprazole—Oedema—Fluorouracil—head and neck cancer	0.000143	0.00181	CcSEcCtD
Lansoprazole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000143	0.00181	CcSEcCtD
Lansoprazole—Connective tissue disorder—Docetaxel—head and neck cancer	0.000143	0.00181	CcSEcCtD
Lansoprazole—Asthenia—Hydroxyurea—head and neck cancer	0.000142	0.00181	CcSEcCtD
Lansoprazole—Urethral disorder—Docetaxel—head and neck cancer	0.000142	0.00181	CcSEcCtD
Lansoprazole—Infection—Fluorouracil—head and neck cancer	0.000142	0.0018	CcSEcCtD
Lansoprazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.00014	0.00178	CcSEcCtD
Lansoprazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00014	0.00178	CcSEcCtD
Lansoprazole—Visual impairment—Docetaxel—head and neck cancer	0.00014	0.00178	CcSEcCtD
Lansoprazole—Tachycardia—Fluorouracil—head and neck cancer	0.000139	0.00177	CcSEcCtD
Lansoprazole—Vomiting—Vinblastine—head and neck cancer	0.000138	0.00176	CcSEcCtD
Lansoprazole—CYP1B1—connective tissue—head and neck cancer	0.000137	0.0242	CbGeAlD
Lansoprazole—Erythema multiforme—Docetaxel—head and neck cancer	0.000137	0.00174	CcSEcCtD
Lansoprazole—Headache—Vinblastine—head and neck cancer	0.000136	0.00173	CcSEcCtD
Lansoprazole—Anorexia—Fluorouracil—head and neck cancer	0.000136	0.00173	CcSEcCtD
Lansoprazole—Diarrhoea—Hydroxyurea—head and neck cancer	0.000136	0.00172	CcSEcCtD
Lansoprazole—Eye disorder—Docetaxel—head and neck cancer	0.000136	0.00172	CcSEcCtD
Lansoprazole—Cardiac disorder—Docetaxel—head and neck cancer	0.000135	0.00171	CcSEcCtD
Lansoprazole—Hypotension—Fluorouracil—head and neck cancer	0.000134	0.00169	CcSEcCtD
Lansoprazole—Angiopathy—Docetaxel—head and neck cancer	0.000132	0.00167	CcSEcCtD
Lansoprazole—Dizziness—Hydroxyurea—head and neck cancer	0.000131	0.00167	CcSEcCtD
Lansoprazole—Immune system disorder—Docetaxel—head and neck cancer	0.000131	0.00166	CcSEcCtD
Lansoprazole—Mediastinal disorder—Docetaxel—head and neck cancer	0.000131	0.00166	CcSEcCtD
Lansoprazole—Chills—Docetaxel—head and neck cancer	0.00013	0.00165	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00013	0.00165	CcSEcCtD
Lansoprazole—Arrhythmia—Docetaxel—head and neck cancer	0.00013	0.00165	CcSEcCtD
Lansoprazole—Nausea—Vinblastine—head and neck cancer	0.000129	0.00164	CcSEcCtD
Lansoprazole—Insomnia—Fluorouracil—head and neck cancer	0.000129	0.00164	CcSEcCtD
Lansoprazole—Paraesthesia—Fluorouracil—head and neck cancer	0.000128	0.00163	CcSEcCtD
Lansoprazole—Alopecia—Docetaxel—head and neck cancer	0.000128	0.00163	CcSEcCtD
Lansoprazole—Dyspnoea—Fluorouracil—head and neck cancer	0.000127	0.00162	CcSEcCtD
Lansoprazole—Mental disorder—Docetaxel—head and neck cancer	0.000127	0.00161	CcSEcCtD
Lansoprazole—Somnolence—Fluorouracil—head and neck cancer	0.000127	0.00161	CcSEcCtD
Lansoprazole—Malnutrition—Docetaxel—head and neck cancer	0.000126	0.0016	CcSEcCtD
Lansoprazole—Erythema—Docetaxel—head and neck cancer	0.000126	0.0016	CcSEcCtD
Lansoprazole—Vomiting—Hydroxyurea—head and neck cancer	0.000126	0.0016	CcSEcCtD
Lansoprazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000126	0.0016	CcSEcCtD
Lansoprazole—Rash—Hydroxyurea—head and neck cancer	0.000125	0.00159	CcSEcCtD
Lansoprazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000125	0.00159	CcSEcCtD
Lansoprazole—Headache—Hydroxyurea—head and neck cancer	0.000124	0.00158	CcSEcCtD
Lansoprazole—Decreased appetite—Fluorouracil—head and neck cancer	0.000124	0.00158	CcSEcCtD
Lansoprazole—Dysgeusia—Docetaxel—head and neck cancer	0.000124	0.00157	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000123	0.00157	CcSEcCtD
Lansoprazole—Back pain—Docetaxel—head and neck cancer	0.000122	0.00155	CcSEcCtD
Lansoprazole—Pain—Fluorouracil—head and neck cancer	0.000122	0.00155	CcSEcCtD
Lansoprazole—Muscle spasms—Docetaxel—head and neck cancer	0.000122	0.00154	CcSEcCtD
Lansoprazole—Nausea—Hydroxyurea—head and neck cancer	0.000118	0.0015	CcSEcCtD
Lansoprazole—Feeling abnormal—Fluorouracil—head and neck cancer	0.000118	0.00149	CcSEcCtD
Lansoprazole—Anaemia—Docetaxel—head and neck cancer	0.000117	0.00148	CcSEcCtD
Lansoprazole—ABCG2—parotid gland—head and neck cancer	0.000116	0.0204	CbGeAlD
Lansoprazole—Urticaria—Fluorouracil—head and neck cancer	0.000114	0.00144	CcSEcCtD
Lansoprazole—Syncope—Docetaxel—head and neck cancer	0.000113	0.00144	CcSEcCtD
Lansoprazole—Leukopenia—Docetaxel—head and neck cancer	0.000113	0.00144	CcSEcCtD
Lansoprazole—Body temperature increased—Fluorouracil—head and neck cancer	0.000113	0.00143	CcSEcCtD
Lansoprazole—Palpitations—Docetaxel—head and neck cancer	0.000112	0.00142	CcSEcCtD
Lansoprazole—ABCG2—saliva-secreting gland—head and neck cancer	0.000111	0.0196	CbGeAlD
Lansoprazole—Loss of consciousness—Docetaxel—head and neck cancer	0.000111	0.00141	CcSEcCtD
Lansoprazole—CYP1A1—parotid gland—head and neck cancer	0.00011	0.0194	CbGeAlD
Lansoprazole—Cough—Docetaxel—head and neck cancer	0.00011	0.0014	CcSEcCtD
Lansoprazole—Convulsion—Docetaxel—head and neck cancer	0.00011	0.00139	CcSEcCtD
Lansoprazole—Hypertension—Docetaxel—head and neck cancer	0.000109	0.00138	CcSEcCtD
Lansoprazole—Myalgia—Docetaxel—head and neck cancer	0.000108	0.00137	CcSEcCtD
Lansoprazole—Chest pain—Docetaxel—head and neck cancer	0.000108	0.00137	CcSEcCtD
Lansoprazole—Arthralgia—Docetaxel—head and neck cancer	0.000108	0.00137	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000107	0.00136	CcSEcCtD
Lansoprazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000105	0.00134	CcSEcCtD
Lansoprazole—Dry mouth—Docetaxel—head and neck cancer	0.000105	0.00134	CcSEcCtD
Lansoprazole—Confusional state—Docetaxel—head and neck cancer	0.000104	0.00132	CcSEcCtD
Lansoprazole—Anaphylactic shock—Docetaxel—head and neck cancer	0.000103	0.00131	CcSEcCtD
Lansoprazole—Oedema—Docetaxel—head and neck cancer	0.000103	0.00131	CcSEcCtD
Lansoprazole—Infection—Docetaxel—head and neck cancer	0.000102	0.0013	CcSEcCtD
Lansoprazole—Shock—Docetaxel—head and neck cancer	0.000101	0.00129	CcSEcCtD
Lansoprazole—Nervous system disorder—Docetaxel—head and neck cancer	0.000101	0.00128	CcSEcCtD
Lansoprazole—Pruritus—Fluorouracil—head and neck cancer	0.000101	0.00128	CcSEcCtD
Lansoprazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.000101	0.00128	CcSEcCtD
Lansoprazole—Tachycardia—Docetaxel—head and neck cancer	0.000101	0.00128	CcSEcCtD
Lansoprazole—CYP1B1—lymphoid tissue—head and neck cancer	0.0001	0.0177	CbGeAlD
Lansoprazole—Skin disorder—Docetaxel—head and neck cancer	0.0001	0.00127	CcSEcCtD
Lansoprazole—Anorexia—Docetaxel—head and neck cancer	9.83e-05	0.00125	CcSEcCtD
Lansoprazole—Diarrhoea—Fluorouracil—head and neck cancer	9.78e-05	0.00124	CcSEcCtD
Lansoprazole—Hypotension—Docetaxel—head and neck cancer	9.64e-05	0.00122	CcSEcCtD
Lansoprazole—Dizziness—Fluorouracil—head and neck cancer	9.45e-05	0.0012	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	9.4e-05	0.00119	CcSEcCtD
Lansoprazole—Insomnia—Docetaxel—head and neck cancer	9.33e-05	0.00118	CcSEcCtD
Lansoprazole—Paraesthesia—Docetaxel—head and neck cancer	9.26e-05	0.00118	CcSEcCtD
Lansoprazole—CYP1A1—epithelium—head and neck cancer	9.22e-05	0.0162	CbGeAlD
Lansoprazole—Dyspnoea—Docetaxel—head and neck cancer	9.2e-05	0.00117	CcSEcCtD
Lansoprazole—Somnolence—Docetaxel—head and neck cancer	9.17e-05	0.00116	CcSEcCtD
Lansoprazole—CYP1B1—thyroid gland—head and neck cancer	9.12e-05	0.016	CbGeAlD
Lansoprazole—Vomiting—Fluorouracil—head and neck cancer	9.09e-05	0.00115	CcSEcCtD
Lansoprazole—Dyspepsia—Docetaxel—head and neck cancer	9.08e-05	0.00115	CcSEcCtD
Lansoprazole—Rash—Fluorouracil—head and neck cancer	9.01e-05	0.00114	CcSEcCtD
Lansoprazole—Dermatitis—Fluorouracil—head and neck cancer	9e-05	0.00114	CcSEcCtD
Lansoprazole—Decreased appetite—Docetaxel—head and neck cancer	8.97e-05	0.00114	CcSEcCtD
Lansoprazole—Headache—Fluorouracil—head and neck cancer	8.95e-05	0.00114	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	8.91e-05	0.00113	CcSEcCtD
Lansoprazole—Fatigue—Docetaxel—head and neck cancer	8.89e-05	0.00113	CcSEcCtD
Lansoprazole—Pain—Docetaxel—head and neck cancer	8.82e-05	0.00112	CcSEcCtD
Lansoprazole—Constipation—Docetaxel—head and neck cancer	8.82e-05	0.00112	CcSEcCtD
Lansoprazole—Feeling abnormal—Docetaxel—head and neck cancer	8.5e-05	0.00108	CcSEcCtD
Lansoprazole—Nausea—Fluorouracil—head and neck cancer	8.49e-05	0.00108	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Docetaxel—head and neck cancer	8.44e-05	0.00107	CcSEcCtD
Lansoprazole—Abdominal pain—Docetaxel—head and neck cancer	8.16e-05	0.00103	CcSEcCtD
Lansoprazole—Body temperature increased—Docetaxel—head and neck cancer	8.16e-05	0.00103	CcSEcCtD
Lansoprazole—CYP1A1—trachea—head and neck cancer	8.15e-05	0.0143	CbGeAlD
Lansoprazole—CYP1B1—head—head and neck cancer	8.09e-05	0.0142	CbGeAlD
Lansoprazole—Hypersensitivity—Docetaxel—head and neck cancer	7.6e-05	0.000964	CcSEcCtD
Lansoprazole—Asthenia—Docetaxel—head and neck cancer	7.4e-05	0.000939	CcSEcCtD
Lansoprazole—Pruritus—Docetaxel—head and neck cancer	7.3e-05	0.000926	CcSEcCtD
Lansoprazole—Diarrhoea—Docetaxel—head and neck cancer	7.06e-05	0.000896	CcSEcCtD
Lansoprazole—Dizziness—Docetaxel—head and neck cancer	6.82e-05	0.000866	CcSEcCtD
Lansoprazole—ABCG2—thyroid gland—head and neck cancer	6.79e-05	0.0119	CbGeAlD
Lansoprazole—Vomiting—Docetaxel—head and neck cancer	6.56e-05	0.000832	CcSEcCtD
Lansoprazole—MAPT—MAPK Signaling Pathway—AKT1—head and neck cancer	6.55e-05	0.000934	CbGpPWpGaD
Lansoprazole—CYP1A2—thyroid gland—head and neck cancer	6.54e-05	0.0115	CbGeAlD
Lansoprazole—Rash—Docetaxel—head and neck cancer	6.5e-05	0.000825	CcSEcCtD
Lansoprazole—Dermatitis—Docetaxel—head and neck cancer	6.5e-05	0.000825	CcSEcCtD
Lansoprazole—Headache—Docetaxel—head and neck cancer	6.46e-05	0.00082	CcSEcCtD
Lansoprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.46e-05	0.000921	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	6.45e-05	0.00092	CbGpPWpGaD
Lansoprazole—CYP1A1—thyroid gland—head and neck cancer	6.45e-05	0.0113	CbGeAlD
Lansoprazole—ABCG2—Metabolism—UROD—head and neck cancer	6.42e-05	0.000916	CbGpPWpGaD
Lansoprazole—Nausea—Docetaxel—head and neck cancer	6.13e-05	0.000777	CcSEcCtD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	5.98e-05	0.000853	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	5.98e-05	0.000853	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	5.98e-05	0.000853	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.93e-05	0.000846	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.91e-05	0.000843	CbGpPWpGaD
Lansoprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.89e-05	0.00084	CbGpPWpGaD
Lansoprazole—CYP1A1—head—head and neck cancer	5.72e-05	0.0101	CbGeAlD
Lansoprazole—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	5.68e-05	0.00081	CbGpPWpGaD
Lansoprazole—CYP1B1—lymph node—head and neck cancer	5.67e-05	0.00997	CbGeAlD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.64e-05	0.000805	CbGpPWpGaD
Lansoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.57e-05	0.000795	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.47e-05	0.000781	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	5.38e-05	0.000767	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CASP8—head and neck cancer	5.36e-05	0.000765	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	5.21e-05	0.000743	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	5.19e-05	0.000741	CbGpPWpGaD
Lansoprazole—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	5.14e-05	0.000733	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	5.12e-05	0.00073	CbGpPWpGaD
Lansoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.03e-05	0.000718	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	4.99e-05	0.000711	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.83e-05	0.000689	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	4.8e-05	0.000685	CbGpPWpGaD
Lansoprazole—ABCB1—epithelium—head and neck cancer	4.79e-05	0.00842	CbGeAlD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.78e-05	0.000682	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	4.78e-05	0.000681	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	4.71e-05	0.000672	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.69e-05	0.000669	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.58e-05	0.000653	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NAT2—head and neck cancer	4.55e-05	0.000648	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	4.53e-05	0.000646	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	4.47e-05	0.000637	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—UROD—head and neck cancer	4.35e-05	0.00062	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	4.26e-05	0.000608	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	4.24e-05	0.000604	CbGpPWpGaD
Lansoprazole—ABCB1—trachea—head and neck cancer	4.23e-05	0.00745	CbGeAlD
Lansoprazole—ABCG2—lymph node—head and neck cancer	4.22e-05	0.00742	CbGeAlD
Lansoprazole—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	4.21e-05	0.0006	CbGpPWpGaD
Lansoprazole—CYP2D6—head—head and neck cancer	4.13e-05	0.00726	CbGeAlD
Lansoprazole—ABCB1—Allograft Rejection—IL2—head and neck cancer	4.05e-05	0.000578	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	4.04e-05	0.000577	CbGpPWpGaD
Lansoprazole—CYP1A1—lymph node—head and neck cancer	4e-05	0.00704	CbGeAlD
Lansoprazole—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	3.99e-05	0.000569	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—DPYD—head and neck cancer	3.99e-05	0.000569	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—UROD—head and neck cancer	3.98e-05	0.000568	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.98e-05	0.000567	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NAT2—head and neck cancer	3.97e-05	0.000567	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	3.92e-05	0.000559	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.89e-05	0.000555	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	3.89e-05	0.000555	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.87e-05	0.000552	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	3.87e-05	0.000552	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	3.83e-05	0.000547	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	3.81e-05	0.000544	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	3.81e-05	0.000544	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	3.81e-05	0.000544	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—YAP1—head and neck cancer	3.78e-05	0.00054	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	3.72e-05	0.00053	CbGpPWpGaD
Lansoprazole—ABCB1—lymphoid tissue—head and neck cancer	3.69e-05	0.00649	CbGeAlD
Lansoprazole—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	3.69e-05	0.000526	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	3.67e-05	0.000523	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	3.64e-05	0.000518	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—UROD—head and neck cancer	3.56e-05	0.000507	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—DPYD—head and neck cancer	3.48e-05	0.000497	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—UROD—head and neck cancer	3.47e-05	0.000495	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	3.44e-05	0.000491	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.37e-05	0.000481	CbGpPWpGaD
Lansoprazole—ABCB1—thyroid gland—head and neck cancer	3.35e-05	0.00589	CbGeAlD
Lansoprazole—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	3.32e-05	0.000474	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—YAP1—head and neck cancer	3.31e-05	0.000472	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	3.28e-05	0.000467	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—UROD—head and neck cancer	3.27e-05	0.000466	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—UROD—head and neck cancer	3.24e-05	0.000462	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	3.15e-05	0.000449	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.11e-05	0.000444	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	3.11e-05	0.000443	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.09e-05	0.000441	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.08e-05	0.000439	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	3.06e-05	0.000437	CbGpPWpGaD
Lansoprazole—ABCB1—head—head and neck cancer	2.97e-05	0.00523	CbGeAlD
Lansoprazole—CYP1B1—Metabolism—NAT2—head and neck cancer	2.93e-05	0.000418	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.84e-05	0.000405	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—UROD—head and neck cancer	2.77e-05	0.000395	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.76e-05	0.000393	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NAT2—head and neck cancer	2.67e-05	0.00038	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.65e-05	0.000378	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—DPYD—head and neck cancer	2.57e-05	0.000366	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.56e-05	0.000366	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.54e-05	0.000362	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.53e-05	0.000361	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.52e-05	0.000359	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.48e-05	0.000354	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—YAP1—head and neck cancer	2.44e-05	0.000348	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.43e-05	0.000347	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.4e-05	0.000342	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—DPYD—head and neck cancer	2.34e-05	0.000333	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—TYMS—head and neck cancer	2.27e-05	0.000324	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.27e-05	0.000324	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GSTM1—head and neck cancer	2.25e-05	0.00032	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—YAP1—head and neck cancer	2.22e-05	0.000316	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.16e-05	0.000308	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GPX1—head and neck cancer	2.15e-05	0.000307	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.15e-05	0.000307	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—UROD—head and neck cancer	2.14e-05	0.000305	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP1A1—head and neck cancer	2.13e-05	0.000304	CbGpPWpGaD
Lansoprazole—ABCB1—lymph node—head and neck cancer	2.08e-05	0.00366	CbGeAlD
Lansoprazole—CYP2C18—Metabolism—TYMS—head and neck cancer	1.99e-05	0.000283	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GSTM1—head and neck cancer	1.96e-05	0.00028	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.95e-05	0.000278	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.92e-05	0.000273	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.88e-05	0.000268	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GPX1—head and neck cancer	1.88e-05	0.000268	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP1A1—head and neck cancer	1.86e-05	0.000265	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.83e-05	0.000261	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NAT2—head and neck cancer	1.8e-05	0.000257	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.76e-05	0.000251	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.75e-05	0.000249	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.74e-05	0.000248	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.7e-05	0.000242	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NAT2—head and neck cancer	1.65e-05	0.000236	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.61e-05	0.000229	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.6e-05	0.000228	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—DPYD—head and neck cancer	1.58e-05	0.000226	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.57e-05	0.000224	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.55e-05	0.000221	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.53e-05	0.000218	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.53e-05	0.000218	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—YAP1—head and neck cancer	1.5e-05	0.000214	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NAT2—head and neck cancer	1.48e-05	0.000211	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—TYMS—head and neck cancer	1.46e-05	0.000209	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—DPYD—head and neck cancer	1.45e-05	0.000207	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GSTM1—head and neck cancer	1.45e-05	0.000206	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NAT2—head and neck cancer	1.44e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.43e-05	0.000204	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.42e-05	0.000202	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GPX1—head and neck cancer	1.39e-05	0.000198	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—YAP1—head and neck cancer	1.38e-05	0.000196	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000196	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NAT2—head and neck cancer	1.36e-05	0.000194	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NAT2—head and neck cancer	1.35e-05	0.000192	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TYMS—head and neck cancer	1.33e-05	0.00019	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.33e-05	0.000189	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTM1—head and neck cancer	1.32e-05	0.000188	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—DPYD—head and neck cancer	1.29e-05	0.000185	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.28e-05	0.000183	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—head and neck cancer	1.27e-05	0.000181	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—DPYD—head and neck cancer	1.26e-05	0.00018	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GPX1—head and neck cancer	1.26e-05	0.00018	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP1A1—head and neck cancer	1.25e-05	0.000178	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—YAP1—head and neck cancer	1.23e-05	0.000175	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.22e-05	0.000174	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.21e-05	0.000173	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—YAP1—head and neck cancer	1.2e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—DPYD—head and neck cancer	1.19e-05	0.00017	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—DPYD—head and neck cancer	1.18e-05	0.000168	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NAT2—head and neck cancer	1.15e-05	0.000164	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—YAP1—head and neck cancer	1.13e-05	0.000161	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.13e-05	0.000161	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.13e-05	0.000161	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—YAP1—head and neck cancer	1.12e-05	0.00016	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—head and neck cancer	1.11e-05	0.000158	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTEN—head and neck cancer	1.1e-05	0.000157	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.08e-05	0.000155	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.03e-05	0.000148	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—DPYD—head and neck cancer	1.01e-05	0.000144	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.84e-06	0.00014	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTEN—head and neck cancer	9.65e-06	0.000138	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—YAP1—head and neck cancer	9.57e-06	0.000137	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.23e-06	0.000132	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.02e-06	0.000129	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TYMS—head and neck cancer	9.02e-06	0.000129	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTM1—head and neck cancer	8.91e-06	0.000127	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NAT2—head and neck cancer	8.88e-06	0.000127	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GPX1—head and neck cancer	8.53e-06	0.000122	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.42e-06	0.00012	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TYMS—head and neck cancer	8.27e-06	0.000118	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—head and neck cancer	8.17e-06	0.000117	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—head and neck cancer	8.16e-06	0.000116	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.05e-06	0.000115	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX1—head and neck cancer	7.82e-06	0.000112	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—head and neck cancer	7.79e-06	0.000111	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—DPYD—head and neck cancer	7.79e-06	0.000111	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1A1—head and neck cancer	7.74e-06	0.00011	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—head and neck cancer	7.42e-06	0.000106	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—YAP1—head and neck cancer	7.39e-06	0.000105	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TYMS—head and neck cancer	7.38e-06	0.000105	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.34e-06	0.000105	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—head and neck cancer	7.29e-06	0.000104	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TYMS—head and neck cancer	7.2e-06	0.000103	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.19e-06	0.000103	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—head and neck cancer	7.12e-06	0.000102	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTEN—head and neck cancer	7.11e-06	0.000101	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—head and neck cancer	6.98e-06	9.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.94e-06	9.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1A1—head and neck cancer	6.91e-06	9.86e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—head and neck cancer	6.82e-06	9.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—head and neck cancer	6.81e-06	9.71e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TYMS—head and neck cancer	6.79e-06	9.68e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1A1—head and neck cancer	6.75e-06	9.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TYMS—head and neck cancer	6.73e-06	9.59e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—head and neck cancer	6.71e-06	9.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—head and neck cancer	6.65e-06	9.48e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTEN—head and neck cancer	6.47e-06	9.23e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—head and neck cancer	6.42e-06	9.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—head and neck cancer	6.37e-06	9.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.36e-06	9.08e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—head and neck cancer	6.36e-06	9.08e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1A1—head and neck cancer	6.36e-06	9.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1A1—head and neck cancer	6.3e-06	8.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.27e-06	8.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TYMS—head and neck cancer	5.75e-06	8.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—head and neck cancer	5.68e-06	8.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.68e-06	8.1e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—head and neck cancer	5.56e-06	7.93e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—head and neck cancer	5.44e-06	7.76e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.39e-06	7.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.18e-06	7.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—head and neck cancer	5.02e-06	7.17e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—head and neck cancer	5.02e-06	7.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—head and neck cancer	4.61e-06	6.57e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—head and neck cancer	4.57e-06	6.51e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TYMS—head and neck cancer	4.44e-06	6.33e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.43e-06	6.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.39e-06	6.25e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTEN—head and neck cancer	4.38e-06	6.25e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—head and neck cancer	4.2e-06	5.99e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.16e-06	5.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—head and neck cancer	4.11e-06	5.86e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—head and neck cancer	4.1e-06	5.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTEN—head and neck cancer	4.02e-06	5.73e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—head and neck cancer	4.01e-06	5.72e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.78e-06	5.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.75e-06	5.35e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—head and neck cancer	3.73e-06	5.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTEN—head and neck cancer	3.59e-06	5.11e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTEN—head and neck cancer	3.5e-06	4.99e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTEN—head and neck cancer	3.3e-06	4.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTEN—head and neck cancer	3.27e-06	4.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—head and neck cancer	3.2e-06	4.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—head and neck cancer	3.09e-06	4.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.83e-06	4.04e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTEN—head and neck cancer	2.79e-06	3.98e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.53e-06	3.61e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—head and neck cancer	2.52e-06	3.6e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.47e-06	3.53e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.47e-06	3.52e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—head and neck cancer	2.33e-06	3.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—head and neck cancer	2.31e-06	3.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.31e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTEN—head and neck cancer	2.16e-06	3.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—head and neck cancer	2.07e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—head and neck cancer	2.02e-06	2.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.97e-06	2.81e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—head and neck cancer	1.9e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—head and neck cancer	1.88e-06	2.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—head and neck cancer	1.61e-06	2.3e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.52e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—head and neck cancer	1.24e-06	1.77e-05	CbGpPWpGaD
